SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9755MARLBOROUGH, Mass., Oct 23, 2006 (BUSINESS WIRE) -- Sepracor Inc. (SEPR, Trade) Iamarangerboy-10/23/2006
9754Xopenex Medicare decision due out imminently (of course it has been due out for Robohogs-10/21/2006
9753Well MNTA does have the trial coming up Dec 4-6. That could produce a binary evIRWIN JAMES FRANKEL-10/20/2006
9752The volatilities of the options are still very high (though nowhere near others Rocky9-10/20/2006
9751sny is not substantially down... would be difficult to ascribe the now 1.75 lossIamarangerboy-10/18/2006
9750Still no news on ped extension for Ambien. 10/21 is the end of exclusivity. Prkenhott-10/18/2006
9749Monthly scripts: 2006 March 749 April 101,879 May 235,770 June 299,985 July 32Rocky9-10/18/2006
9748of course, the real value to the Lunesta 7 day trial is that docs that have not Iamarangerboy-10/17/2006
9747But note that Ambien CR has a similar "7-day free" offer out there (exBiomaven-10/17/2006
9746"But is this because of the "free 7 days" coupon?" At leastRocky9-10/17/2006
9745That's a decent trajectory for Lunesta over the last several weeks. But is tBiomaven-10/16/2006
9744Thanks for the update. Someone should tell Goldman Sachs the trend is up.kenhott-10/16/2006
9743Lunesta 137,446 Xoponex MDI 26,359Rocky9-10/16/2006
9742Gaboxadol delayed by slow enrollment: >>8:01AM Merck announces that submituck-10/13/2006
9741Drug industry revs up ad spending Lunesta wakes up drug advertising market that Icebrg-10/11/2006
9740Lunesta 134,960 Xoponex MDI 26,208Rocky9-10/10/2006
9739Share is up as measured by Citi from 13.8 to 15.1% for new Rx's over last 4-Robohogs-10/9/2006
9738Goldman also has Brovana sales at $250MM, in 2010. They too had a launch in Q2. Rocky9-10/9/2006
9737citigroup sees 250 million peak sales for Brovana. Sepracor has previously notelhazarra-10/9/2006
9736Trx 134960 Nrx 81852 Nrx market share 15,1 lunesta continues its upswing.lhazarra-10/9/2006
9735Dey DuoNeb (albuterol and ipratropium solution) sold about $310 million in 2005.bio_kruncher-10/9/2006
9734I think peak $150-$200m. Peter thinks it maybe much higher. I hope he is rightkenhott-10/9/2006
9733<i>peak at $100MM?</i> I think this product may be something of a sBiomaven-10/9/2006
9732Interesting that Wachovia had revenue stating in 2Q07, with stocking at ~$8mm, aRocky9-10/7/2006
9731I have seen $250-350 MM in some reports. JonRobohogs-10/7/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News